Search This Blog

Monday, March 2, 2020

Heron Therapeutics EPS misses by $0.09, beats on revenue

Heron Therapeutics (NASDAQ:HRTX): Q4 GAAP EPS of -$0.65 misses by $0.09.
Revenue of $35.1M (+21.7% Y/Y) beats by $3.29M.
https://seekingalpha.com/news/3547353-heron-therapeutics-eps-misses-0_09-beats-on-revenue

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.